Zeng Ying, Zhuang Shunhui, Gloddek Jutta, Tseng Chi-Chuan, Boss Gerry R, Pilz Renate B
Department of Medicine and Cancer Center, University of California at San Diego, La Jolla, California 92093.
Section of Gastroenterology, Boston University School of Medicine, Boston, Massachusetts 02118.
J Biol Chem. 2006 Jun 23;281(25):16951-16961. doi: 10.1074/jbc.M602099200. Epub 2006 Apr 20.
Type I cGMP-dependent protein kinase (PKG I) plays a major role in vascular homeostasis by mediating smooth muscle relaxation in response to nitric oxide, but little is known about the regulation of PKG I expression in smooth muscle cells. We found opposing effects of RhoA and Rac1 on cellular PKG I expression: (i) cell density-dependent changes in PKG I expression varied directly with Rac1 activity and inversely with RhoA activity; (ii) RhoA activation by calpeptin suppressed PKG I, whereas RhoA down-regulation by small interfering RNA increased PKG I expression; and (iii) PKG I promoter activity was suppressed in cells expressing active RhoA or Rho-kinase but was enhanced in cells expressing active Rac1 or a dominant negative RhoA. Sp1 consensus sequences in the PKG I promoter were required for Rho regulation and bound nuclear proteins in a cell density-dependent manner, including the Krüppel-like factor 4 (KLF4). KLF4 was identified as a major trans-acting factor at two proximal Sp1 sites; active RhoA suppressed KLF4 DNA binding and trans-activation potential on the PKG I promoter. Experiments with actin-binding agents suggested that RhoA could regulate KLF4 via its ability to induce actin polymerization. Regulation of PKG I expression by RhoA may explain decreased PKG I levels in vascular smooth muscle cells found in some models of hypertension and vascular injury.
I型环磷酸鸟苷依赖性蛋白激酶(PKG I)通过介导一氧化氮引起的平滑肌舒张,在血管稳态中发挥主要作用,但关于平滑肌细胞中PKG I表达的调控知之甚少。我们发现RhoA和Rac1对细胞内PKG I表达具有相反的作用:(i)PKG I表达的细胞密度依赖性变化与Rac1活性直接相关,与RhoA活性呈负相关;(ii)钙蛋白酶抑制剂激活RhoA可抑制PKG I,而小干扰RNA下调RhoA则增加PKG I表达;(iii)在表达活性RhoA或Rho激酶的细胞中PKG I启动子活性受到抑制,而在表达活性Rac1或显性负性RhoA的细胞中则增强。PKG I启动子中的Sp1共有序列是Rho调控所必需的,并以细胞密度依赖性方式结合核蛋白,包括Krüppel样因子4(KLF4)。KLF4被确定为两个近端Sp1位点的主要反式作用因子;活性RhoA抑制KLF4与PKG I启动子的DNA结合及反式激活潜能。肌动蛋白结合剂的实验表明,RhoA可通过其诱导肌动蛋白聚合的能力来调节KLF4。RhoA对PKG I表达的调控可能解释了在某些高血压和血管损伤模型中血管平滑肌细胞中PKG I水平降低的现象。